Perspective
Published on 01 Nov 2021
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.735912
- 8,985 views
- 20 citations
Type at least 3 characters
29 articles
Articles
Opinion
Published on 16 Aug 2021
Social Pharmacology as an Underappreciated Field in Medical Education: A Single Medical School’s Experience
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.714707
- 3,561 views
- 4 citations
Mini Review
Published on 07 Jan 2019
GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01495
- 31,380 views
- 3 citations
Perspective
Published on 10 Dec 2018
Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01451
- 4,184 views
- 5 citations
Original Research
Published on 29 Oct 2018
Smarter Than Thou, Holier Than Thou: The Dynamic Interplay Between Cognitive and Moral Enhancement
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01189
- 5,255 views
- 13 citations
Perspective
Published on 16 Oct 2018
Palliative Care: Taking the Long View
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01140
- 16,459 views
- 15 citations
Perspective
Published on 05 Oct 2018
Childhood Brain Development, the Educational Achievement Gap, and Cognitive Enhancement
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01142
- 9,996 views
- 5 citations
Review
Published on 28 Aug 2018
Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00961
- 194,330 views
- 48 citations
Hypothesis and Theory
Published on 20 Aug 2018
Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00898
- 16,033 views
- 5 citations
Perspective
Published on 29 Mar 2018
Ethical Challenges for an Understanding of Suffering: Voluntary Stopping of Eating and Drinking and the Wish to Hasten Death in Advanced Patients
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00294
- 7,397 views
- 7 citations
Perspective
Published on 22 Jan 2018
How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00003
- 19,679 views
- 32 citations
Data Report
Published on 08 Jan 2018
Socioeconomic Inequalities in Overweight and Obesity in Serbia: Data from 2013 National Health Survey
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00967
- 6,071 views
- 13 citations
Review
Published on 21 Jul 2017
Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees
in ELSI in Science and Genetics
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00488
- 6,152 views
- 13 citations